Skip to main content

Find Clinical Trials

Home
Conditions
Lymphoma, Non-Hodgkin

Clinical trial condition

Lymphoma, Non-Hodgkin

Explore clinical trials studying Lymphoma, Non-Hodgkin. Study availability and eligibility vary by location and protocol.

2,778 public trials 699 recruiting studies

Refine in advanced search Browse all conditions

Lymphoma, Non-Hodgkin trial results

Completed

A Study Evaluating CPI-1205 in Patients With B-Cell Lymphomas

NCT02395601

Conditions: B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations: Horizon Oncology Center Lafayette, Indiana, United States

Massachusetts General Hospital Boston, Massachusetts, United States

University of Nebraska Medical Center Omaha, Nebraska, United States

John Theurer Cancer Center Hackensack, New Jersey, United States

View Trial Details

Completed

Clofarabine in Treating Patients With T-Cell or Natural Killer-Cell Non-Hodgkin's Lymphoma That Has Relapsed or Not Responded to Previous Treatment

NCT00416351

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +21 more
Locations: Memorial Sloan Kettering Cancer Center New York, United States

James P. Wilmot Cancer Center at University of Rochester Medical Center Rochester, New York, United States

Cleveland Clinic Taussig Cancer Center Cleveland, Ohio, United States

View Trial Details

Completed

Cell-free Circulating DNA in Primary Cutaneous Lymphomas

NCT02883517

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +11 more
Locations: University Hospital of Bordeaux - Hospital Saint André Bordeaux, France

View Trial Details

Completed

A Study to Evaluate Safety, Tolerability, PK and PD of HLX01 in Patients With CD20-positive B-cell Lymphomas

NCT03218072

Conditions: B-Cell Lymphomas, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations: Not specified

View Trial Details

Completed

A Pharmacokinetic and Pharmacodynamic Study Comparing HLX01 And Rituximab in Patients With CD20-Positive, B-cell Lymphoma

NCT02584920

Conditions: B-cell Non Hodgkin's Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations: Not specified

View Trial Details

Completed

Clinical Study to Compare the Efficacy and Safety of Rituximab Biosimilar HLX01 and Rituximab in Combination With CHOP, in Previously Untreated Subjects With CD20+ DLBCL

NCT02787239

Conditions: B-cell Non Hodgkin's Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations: Cancer Hospital, Chinese Academy of Medical Sciences Beijing, China

View Trial Details

Completed

Subcutaneous Recombinant Human IL-15 (s.c. rhIL-15) and Alemtuzumab for People With Refractory or Relapsed Chronic and Acute Adult T-cell Leukemia (ATL)

NCT02689453

Conditions: Adult T-Cell Leukemia (ATL), Cutaneous T Cell Lymphoma (CTCL), Hematologic Diseases, +21 more
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States

View Trial Details

Completed

A Study of GC007F CAR-T Cell Immunotherapy for Relapsed or Refractory B- ALL

NCT03825718

Conditions: B-cell Acute Lymphoblastic Leukemia, Burkitt Lymphoma, DNA Virus Infections, +15 more
Locations: Hebei Yanda Ludaopei Hospital Sanhe, Hebei, China

View Trial Details

Completed

Rituximab, Fludarabine, Mitoxantrone, Dexamethasone (R-FND) Plus Zevalin for High-Risk Follicular Lymphoma

NCT00290511

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations: University of Texas MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

FLASH [Fluorescent Light Activated Synthetic Hypericin] Clinical Study: Topical SGX301 (Synthetic Hypericin) for the Treatment of Cutaneous T-Cell Lymphoma (Mycosis Fungoides)

NCT02448381

Conditions: Cutaneous T-Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +10 more
Locations: University of Alabama Birmingham Birmingham, Alabama, United States

University of Arizona Phoenix, Arizona, United States

Mayo Clinic Scottsdale, Arizona, United States

University of Arkansas Little Rock, Arkansas, United States

View all 33 locations

View Trial Details